Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005025042 | SCV005663027 | uncertain significance | Pseudohyperaldosteronism type 2; Autosomal dominant pseudohypoaldosteronism type 1 | 2024-06-04 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000009088 | SCV000029305 | pathogenic | Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy | 2000-07-07 | flagged submission | literature only | |
Prevention |
RCV004730839 | SCV005339150 | pathogenic | NR3C2-related disorder | 2024-08-29 | no assertion criteria provided | clinical testing | The NR3C2 c.2429C>T variant is predicted to result in the amino acid substitution p.Ser810Leu. This variant was reported to segregate in a large family of individuals with early-onset hypertension; and in several female individuals, the condition was further exacerbated during pregnancy (Geller et al. 2000. PubMed ID: 10884226). Functional studies indicate this variant results in constitutive mineralocorticoid receptor activity by increasing the steroid-receptor complex (Geller et al. 2000. PubMed ID: 10884226; Pinon et al. 2004. PubMed ID: 15134816). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. |